master's thesis
The reclassification of prescription drugs to the non-prescription status: what are the risks?

Daniel Zlatić (2015)
University of Zagreb
Faculty of Pharmacy and Biochemistry
Cite this document...

Zlatić, D. (2015). Reklasifikacija lijekova u bezreceptni status: koje opasnosti skriva? (Master's thesis). Retrieved from https://urn.nsk.hr/urn:nbn:hr:163:619693

Zlatić, Daniel. "Reklasifikacija lijekova u bezreceptni status: koje opasnosti skriva?." Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, 2015. https://urn.nsk.hr/urn:nbn:hr:163:619693

Zlatić, Daniel. "Reklasifikacija lijekova u bezreceptni status: koje opasnosti skriva?." Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, 2015. https://urn.nsk.hr/urn:nbn:hr:163:619693

Zlatić, D. (2015). 'Reklasifikacija lijekova u bezreceptni status: koje opasnosti skriva?', Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, accessed 18 August 2019, https://urn.nsk.hr/urn:nbn:hr:163:619693

Zlatić D. Reklasifikacija lijekova u bezreceptni status: koje opasnosti skriva? [Master's thesis]. Zagreb: University of Zagreb, Faculty of Pharmacy and Biochemistry; 2015 [cited 2019 August 18] Available at: https://urn.nsk.hr/urn:nbn:hr:163:619693

D. Zlatić, "Reklasifikacija lijekova u bezreceptni status: koje opasnosti skriva?", Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, 2015. Available at: https://urn.nsk.hr/urn:nbn:hr:163:619693